Over the last five years, Microsoft has delivered a return nearly four times greater than Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B). Buffett once stated that he didn't initially invest in Microsoft because of "stupidity." Read More...
TipRanks
Pyxis Stock Is Up 170% This Week. How Much Higher Can It Go?
It’s been a good week for investors of Pyxis Oncology (NASDAQ:PYXS), to say the least. Over the past 4 sessions Pyxis shares have gained 170%, bringing the year-to-date haul to a mighty 340%. This biotech micro-cap is backed by Pfizer, which is largely responsible for the recent rally. According to a recent SEC filing, the pharma giant loaded up on 1,811,594 PYXS shares earlier this month for a total sum of $5 million, paying $2.76 per share. This raised Pfizer’s ownership in Pyxis to 5,952,263
Add Comment